Report Highlights

U.S. Refurbished Medical Devices: Market Overview

The United States is the largest and most structurally fragmented refurbished medical devices market globally, with an estimated USD 3.9 billion in 2024 transactions across imaging, surgical, patient monitoring and laboratory equipment. Unlike Europe, where public tenders dominate, U.S. demand is shaped by private hospital systems, group purchasing organizations and the reimbursement logic of Medicare and commercial payers. Remanufacturers are legally treated as manufacturers under FDA rules, which raises compliance costs for every entrant.

Structurally, the market splits into two tiers: OEM-certified pre-owned programs run by GE HealthCare, Siemens Healthineers and Philips, which carry warranties and service contracts, and independent refurbishers serving smaller facilities at lower prices. Independent operators hold roughly 45 percent of unit volume in orthopedic and surgical categories, while OEMs dominate high-value imaging, according to analyst channel checks. This split means entry strategy depends on which tier a company can credibly serve.

Growth Drivers in U.S. Refurbished Medical Devices

Hospital capital budgets are the primary demand driver. Margin pressure from Medicare inpatient payment updates, which have trailed hospital cost inflation, pushes systems toward certified refurbished imaging rather than new capital. The Centers for Medicare and Medicaid Services shift of procedures to outpatient settings, including the expansion of the Ambulatory Surgical Center covered procedures list, is adding demand for lower-cost surgical equipment in freestanding facilities. CMS continues to add procedures to that list in its annual rules.

Federal policy supports reuse. FDA guidance on reprocessed single-use devices, combined with its premarket pathway for remanufactured devices, lets qualified third-party reprocessors compete on clinical equivalence rather than price alone. Sustainability reporting by large health systems also favors reuse, because refurbished imaging avoids the embodied carbon of new manufacturing, a factor now cited in procurement scorecards at several academic medical centers. Remanufactured devices also qualify for the same reimbursement codes as new equipment.

Market Restraints and Entry Barriers

FDA registration and remanufacturing obligations represent the first barrier. Refurbishers that substantially alter a device are regulated as manufacturers under 21 CFR Part 820 and must maintain complaint files, corrective and preventive action records, and Medical Device Reporting obligations under 21 CFR Part 803. The Quality Management System Regulation, aligning with ISO 13485, takes full effect February 2, 2026, raising audit requirements for small refurbishers. Each device model requires separate validation documentation, adding months to market entry.

Incumbent advantages and OEM service lock-in create the second barrier. GE HealthCare, Siemens Healthineers and Philips control software licensing, service manuals and parts availability, and several imaging platforms require OEM-authorized service tools to calibrate after repair. Group purchasing contracts with Vizient and Premier Inc. often bundle new equipment with service agreements, limiting independent refurbishers' access to hospital tenders. Most state digital right-to-repair laws exclude medical devices, leaving OEM service restrictions intact.

Market Opportunities in the United States

Near-term opportunities concentrate in outpatient imaging and surgical capital. Certified pre-owned CT and MRI systems for ambulatory imaging centers represent an addressable pool estimated at USD 900 million annually, driven by replacement cycles of seven to ten years. Rural hospitals in the Southeast and Plains states, where Critical Access Hospital status constrains capital, form the highest-priority buyer base for financed refurbished equipment programs. Fixed-term leasing structures lower the upfront cost for these facilities, shifting entry economics toward recurring service revenue.

Surgical and orthopedic categories offer high-margin refurbishment potential. Refurbished surgical instrument trays, powered orthopedic tools and reprocessed reusable instruments serve ambulatory surgical centers, a segment accelerated by CMS's 2020 addition of total knee arthroplasty to the ASC covered procedures list. Independent refurbishers can capture service margins on retired first-generation da Vinci systems traded in by hospitals upgrading to newer Intuitive Surgical platforms.

Market at a Glance

Leading Market Participants

• GE HealthCare
• Siemens Healthineers
• Philips
• Canon Medical Systems USA
• Block Imaging
• Stryker
• Medtronic
• Intuitive Surgical
• Cardinal Health
• Johnson & Johnson MedTech

Regulatory and Policy Environment

The FDA governs refurbished devices primarily through 21 CFR Part 820, which requires remanufacturers to establish design controls, purchasing controls and complaint handling, with the Quality Management System Regulation aligning these requirements with ISO 13485 from February 2, 2026. Medical Device Reporting under 21 CFR Part 803 and Corrections and Removals under 21 CFR Part 806 apply to all reprocessed equipment. The FDA's 510(k) pathway applies where a refurbisher changes intended use or materially modifies a device.

Reimbursement and procurement rules shape demand indirectly. CMS sets Medicare payment through the Outpatient Prospective Payment System and the Ambulatory Surgical Center payment system, which pay facilities regardless of whether equipment is new or refurbished. The Federal Trade Commission continues to scrutinize OEM repair restrictions under the July 2021 Executive Order on Competition. Refurbished equipment buyers that are businesses benefit from Section 179 expensing, with the 2025 limit set at USD 2.5 million.

Long-Term Outlook for U.S. Refurbished Medical Devices

By 2032, the U.S. refurbished medical devices market is projected to reach USD 7.1 billion, growing at a 7.8 percent CAGR from the 2025 base. Imaging remains the largest category, but orthopedic and ambulatory surgical equipment will gain share as outpatient procedure volumes rise. OEM certified pre-owned programs from GE HealthCare, Siemens Healthineers and Philips will expand their footprint, while independent refurbishers that secure ISO 13485 certification consolidate into regional networks serving hospital groups.

Regulatory enforcement, not demand, will set the market's shape by 2032. FDA audit intensity under the QMSR will compress the field toward well-capitalized operators, narrowing independent pricing advantages. Entrants that hold validated reprocessing lines, multi-state distribution and OEM service authorizations will capture the largest share of growth through 2032. Hospitals will increasingly treat certified refurbishment as a standard procurement option, with the refurbished share of imaging placements expected to rise steadily through the forecast period.